Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Ropes & Gray represented Avista Healthcare Partners, while Foley Hoag represented Organogenesis Holdings, Inc. in the transaction.Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here